Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of N-acetylcysteine and ambroxol for symptom improvement in COPD after acute exacerbation
TCTR20260523016Phase 4Completed
- Sponsor
- Universitas Gadjah Mada
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of acetylcysteine and ambroxol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Universitas Gadjah Mada. Started Oct 2025; status: completed.
02
Drugs
acetylcysteineambroxol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on TCTR20260523016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260523016.